What is the recommended dosage of noradrenaline (norepinephrine) for treating hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Dosing for Hypotension

Norepinephrine should be initiated at 0.1-0.5 mcg/kg/min (approximately 7-35 mcg/min in a 70 kg adult) and titrated to achieve a mean arterial pressure (MAP) of 65 mmHg, with typical maintenance doses ranging from 2-4 mcg/min (0.03-0.06 mcg/kg/min). 1, 2, 3

Initial Dosing and Preparation

Standard concentration: Add 4 mg of norepinephrine to 250 mL of D5W to yield 16 mcg/mL. 2

Starting dose ranges:

  • FDA-approved initial dose: 0.25-0.375 mL/min (8-12 mcg/min of base) 3
  • Contemporary guideline recommendation: 0.1-0.5 mcg/kg/min (7-35 mcg/min in 70 kg adult) 1, 2
  • Average maintenance dose: 2-4 mcg/min (0.03-0.06 mcg/kg/min) 3

Target Blood Pressure

Primary target: MAP ≥65 mmHg 4, 1, 2

The 65 mmHg MAP target has been validated to preserve tissue perfusion in septic shock. 4 However, patients with chronic hypertension or atherosclerosis may require higher targets, while younger normotensive patients may tolerate lower pressures. 4, 5 Titration should be guided by both MAP and markers of tissue perfusion including lactate clearance, urine output (>0.5 mL/kg/h), mental status, and capillary refill. 4, 1

Dose Escalation and Maximum Doses

Titration protocol:

  • Increase by 0.5 mg/h every 4 hours as needed 2
  • Maximum recommended dose: 3 mg/h 2
  • Typical range in septic shock: 0.1-2 mcg/kg/min 2
  • Higher doses (up to 2.5 ± 2.2 mcg/kg/min) may be necessary in severe cases 6

When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, add vasopressin (0.03-0.04 units/min) as second-line therapy rather than continuing to escalate norepinephrine alone. 4, 7

Timing of Initiation

Early administration is critical. Norepinephrine should be started during or immediately after initial fluid resuscitation, particularly in patients with profound hypotension. 1, 8, 9

Indications for early initiation:

  • Systolic blood pressure <70 mmHg despite fluid resuscitation 1
  • Diastolic blood pressure ≤40 mmHg (indicating very low arterial tone) 8
  • Diastolic shock index (heart rate/diastolic BP) ≥3 8
  • Life-threatening hypotension where delaying vasopressors would prolong organ hypoperfusion 8

A randomized trial demonstrated that early norepinephrine (median 93 minutes from ER arrival) achieved shock control by 6 hours in 76.1% of patients versus 48.4% with standard delayed administration, and reduced cardiogenic pulmonary edema (14.4% vs 27.7%) and arrhythmias (11% vs 20%). 9

Fluid Resuscitation Requirements

Minimum 30 mL/kg crystalloid bolus should be administered before or concurrent with norepinephrine initiation. 4, 2 However, in severe hypotension (systolic <70 mmHg), norepinephrine should be started as an emergency measure while fluid resuscitation continues, rather than waiting for complete volume repletion. 4, 1

Administration Route and Safety

Central venous access is strongly preferred to minimize extravasation risk. 1, 2, 3

Peripheral or intraosseous administration can be used temporarily if central access is unavailable, with strict monitoring. 1, 2 Pediatric data shows peripheral administration for median 3 hours was safe without adverse effects. 6

If extravasation occurs: Immediately infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline into the affected area to prevent tissue necrosis. 1, 2, 3

Monitoring Requirements

  • Blood pressure and heart rate every 5-15 minutes during initial titration 2
  • Arterial catheter placement for continuous monitoring in all vasopressor-dependent patients 2, 7
  • Monitor for signs of excessive vasoconstriction: cold extremities, decreased urine output, arrhythmias 2
  • Assess tissue perfusion markers: lactate, mental status, urine output, capillary refill 4, 1

Pediatric Dosing

Starting dose: 0.1-1.0 mcg/kg/min, beginning at the lowest dose and titrating to effect 2

Maximum doses: Up to 5 mcg/kg/min may be necessary in children 2

"Rule of 6" for preparation: 0.6 × body weight (kg) = mg of norepinephrine diluted to 100 mL saline; then 1 mL/h delivers 0.1 mcg/kg/min 2

Critical Precautions

Do not mix with sodium bicarbonate or alkaline solutions in the IV line, as norepinephrine is inactivated in alkaline environments. 2, 3

Avoid abrupt discontinuation: Gradually reduce infusion rate to prevent rebound hypotension. 1, 3

Use cautiously in ischemic heart disease as norepinephrine increases myocardial oxygen demand. 1, 2

Dose-Mortality Relationship

Recent data establishes severity cutoffs based on mortality risk:

  • Low dose: <0.2 mcg/kg/min (14% hospital mortality)
  • Intermediate dose: 0.2-0.4 mcg/kg/min (26.4% hospital mortality)
  • High dose: >0.4 mcg/kg/min (40.2% hospital mortality) 10

These cutoffs help quantify circulatory failure severity and guide decisions about adding second-line agents.

References

Guideline

Role of Pressors in Resuscitation for Treating Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Guideline

Vasopressor Use in Hypotensive Intubated Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.

American journal of respiratory and critical care medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.